Skip to search boxSkip to navigationSkip to main content

HSP90 and HSP70 Proteins are essential for stabilization and activation of WASF3 metastasis-promoting protein

  • Yong Teng
    ,
  • Lambert Ngoka
    ,
  • Yun Mei
    ,
  • Leslieann Lesoon
    ,
  • John K. Cowell(corresponding author)
*Corresponding author for this work
Scholary Output:
Contribution to journal
Article
Peer-review

Open access

Sustainable Development Goals

  • SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well

Abstract

Inactivation of HSP90 and HSP70 leads to loss of invasion in a variety of cancer cell types, presumably as a result of destabilization of, as yet, undefined clients of these molecular chaperones that influence this phenotype. The WASF3 gene has been shown to be up-regulated in high-grade tumors and its down-regulation leads to loss of invasion and metastasis. WASF3 phosphorylation by ABL kinase is essential for its ability to regulate invasion. Mass spectroscopy analysis now shows that HSP90 is present in the WASF3 immunocomplex from prostate cancer cells. Inactivation of HSP90 in these and other cell types does not affect WASF3 stability but prevents its phosphoactivation as a result of destabilization of ABL. HSP70 was also found in the WASF3 immunocomplex and inactivation of HSP70 results in destabilization of WASF3 through proteasome degradation. Knockdown of WASF3, HSP90, and HSP70 individually, all lead to loss of invasion but as knockdown of WASF3 in the presence of robust expression of HSP90/70 has the same effect, it seems that the influence these chaperone proteins have on invasion is mediated, at least in part, by their control over the critical invasion promoting capacity of the WASF3 protein. Overexpression of HSP70 in WASF3 null cells does not enhance invasion. These observations suggest that targeting HSP90/70 may have efficacy in reducing cancer cell invasion.

Publication Information

Output type

Scholary Output:
Contribution to journal
Article
Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Pages 10051-10059 (9 pages)

Journal (Volume, Issue Number)

Journal of Biological Chemistry (Volume 287, Issue 13)

Publication milestones

  • Published - 03/23/2012

Publication status

Published - 03/23/2012

ISSN

0021-9258

Publication IDs

  • Scopus: 84858967994
  • PubMed: 22315230
  • ORCID: /0000-0002-1856-7289/work/62481110

Publication metrics

Metrics

Scopus
citations
SciVal
citations
53
SciVal
FWCI
1.65
SciVal
Author count
5
SciVal
Paper percentile
93
SciVal
Top percentile
10
Fractional count
2
Fractional count
0.40
Fractional count
3
Fractional count
0.60
Fractional count
2
Fractional count
1

PlumX, opens in new tab

Citation count
78
Captures
52

Funding Details

FunderFunding number
NCI
R01CA120510